StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.11+0.02 (+0.96%)

Close on Nov 17, 2026Market cap $214.68MP/E –Yield –

AC Immune pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AC Immune's pe ratio was 10.8× on Feb 26, 2021, against 28.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Feb 26, 202110.8×+3.6
2020Dec 31, 20207.1×−21.2
2017Feb 28, 201728.3×−1.6
2016Dec 30, 201630.0×–

More AC Immune figures

See a number that looks wrong?